VDL Medibus serves as mobile laboratory in fight against COVID-19

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

In Germany, the Deutsche Bahn (DB) Medibuses, built by VDL Bus & Coach, are currently being used in a large-scale study by the Robert Koch Institute (RKI) into the spread of COVID-19. By using the Medibuses, researchers and physicians have access to high-quality laboratory environments, which can also be flexibly deployed in different locations.

The main objectives of the so-called ‘Corona-Monitoring lokal’ study are to map the spread of the virus and to obtain a more complete picture of the number of unreported coronavirus cases. A total of 8,000 citizens from four different areas of Germany are being monitored.

The village of Kupferzell, in the state of Baden-Württemberg, is the first research site that the RKI arrived at with the Medibus. A church concert was held here at the beginning of March, during which 82 people became infected with Coronavirus. Because of this outbreak, Kupferzell instantly became one of Germany’s Coronavirus hotspots. The RKI is now investigating, among other things, how many inhabitants of the village have built up antibodies against the virus and how many of them have been infected without developing any symptoms. A Coronavirus test is therefore being performed on 2000 residents. Blood samples are also taken and the residents are asked for their medical history and social contacts. Participation in the study is entirely voluntary.

In addition to the 2000 residents of Kupferzell, thousands of people from three other areas affected by Coronavirus are also being monitored. These areas are selected on the basis of the latest situation just before the start of the local research. During these various local studies, the Medibuses function as mobile research centres equipped with all conveniences.

The Citea LLE-127 Medibuses for Deutsche Bahn were built by VDL Bus Venlo in cooperation with VDL Bus Heerenveen and VDL Bus Chassis. The bus has been converted into a doctor’s practice in which the 4 rooms (treatment room, consultation room, laboratory and waiting room) are equipped with cupboards and furniture. Each room also has its own air conditioning, and solar panels on the roof provide clean energy so that the bus is less dependent on external power on location.

In October 2019, the DB Medibus won the prestigious German Mobility Award. With its 12.7 metre-long medical practice, Deutsche Bahn is making an innovative contribution to the improvement of the medical infrastructure in Germany. Initially, the DB Medibus was used for medical care in rural areas. In the meantime, numerous applications have demonstrated that the bus can also be used for many other purposes within the healthcare sector.

Latest issue
Advertising
Latest posts
To launch the latest coaches from the Anadolu Isuzu range, EVM Direct Ireland is extending an open invitation to passenger transport operators to join in on…
The Automobile Association (Ireland) is calling upon the Government to introduce free public transport and shared bikes trial across the country for a dedicated…
The 26th edition of the Busworld Europe exhibition will be staged from 7 to 12 October 2023 in Brussels, Belgium. After four years of…
If you didn’t get a chance to join the Tranzaura webinar on 16 February featuring the Driver & Vehicle Standards Authority (DVSA) and Travis Perkins plc, you can…
ADL is preparing its aftermarket in Ireland & the UK for an increase in operator refurbishment requests of both ADL buses and other models…
Leading bus manufacturer Wrightbus was showcasing the capabilities of hydrogen and its part in the UK’s net zero ambitions at a conference last month….
Yutong Bus, a leading global manufacturer of electric buses, led sales of electric buses in Europe last year on the strength of its high-quality…
Limerick native and prominent businessman, Willie Martin of Martin’s Coaches has been elected Chairperson of the Coach Tourism & Transport Council of Ireland (CTTC) following election at the organisation’s…

This website uses cookies in order to improve the site and user experience. By continuing to use it, you agree to our Privacy Policy.